Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Contraceptives Market?

In recent years, there has been a significant expansion in the size of the contraceptives market. It is projected to increase from $27.92 billion in 2024 to $29.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors such as the introduction of the birth control pill, enhanced awareness and education about contraceptives, legal and societal improvements supporting reproductive rights, global projects for population management, and the escalating use of generic and economically priced drugs and devices can all be credited for the growth during the historic period.

In the upcoming years, the contraceptive market is predicted to experience substantial growth, reaching “$40 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 7.7%”. Factors contributing to this growth in the projected period include an increased emphasis on male contraceptives, expanded access to contraception in developing nations, the inclusion of digital health technologies in contraceptive solutions, a surging demand for long-lasting reversible contraceptives (LARCS), and improved access to over-the-counter drugs via online platforms. The forecast period also signals major shifts like advancements in contraceptive technology, a movement towards non-hormonal and natural contraceptive methods, broader over-the-counter access to specific contraceptives, increased focus on discreet and user-friendly contraceptive options and the assimilation of telemedicine in contraceptive counseling and prescriptions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Factor Is Shaping The Future Of The Contraceptives Market?

An escalating prevalence of diseases or illnesses transmitted via sexual interactions is fueling the need for contraceptives. STDs are infections exchanged between individuals predominantly through sexual activities. These diseases typically get conveyed during anal, oral, and vaginal sexual contacts. STDs can also be transmitted via other forms of close physical intimacy. Contraceptives are used as a precautionary measure to control the proliferation of sexually transmitted diseases such as herpes and HPV, which principally spread through intimate skin contact. The Minnesota Department of Health, a health organization in the United States affiliated with the Minnesota state, declared in May 2023, that there had been a 19% ascension in the number of primary and secondary syphilis cases in 2022, from 564 in 2021 to 676 in 2022. Moreover, 20 cases of congenital syphilis in babies were registered in 2022, symbolizing a spike of 42% from 2021 when only 14 cases were reported. Consequently, the climbing numbers of sexually transmitted ailments or diseases are anticipated to reinforce the demand for contraceptives throughout the projection period.

What Is The Segment-Wise Breakdown Of The Contraceptives Market?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Trends Are Redefining The Future Landscape Of The Contraceptives Industry?

Leading businesses in the contraceptives industry are prioritizing the creation of state-of-the-art contraceptives such as the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives. These innovations are aimed at improving user convenience, ramping up efficacy, and providing longer-lasting options for birth control. The goal is to lessen the requirement for regular dosing, enhance reachability, and limit unwanted effects, thus giving more trustworthy and unnoticeable contraceptive answers for people wanting superior management of reproductive health. For instance, in October 2023, the Health and Family Welfare Ministry, an Indian governmental institution unveiled two groundbreaking methods – Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, in a bid to augment family planning facilities. These strategies are incorporated within the National Family Planning Programme and are conceived to boost maternal and child health results. The introduction of these contraceptive inventions is aimed at mitigating maternal and child sickness and death rates by providing a wider spectrum of family planning choices. This campaign mirrors a larger plan to improve reproductive health facilities in Karnataka, ensuring females have access to risk-free and successful contraceptive procedures.

Which Companies Hold The Largest Market Share In The Contraceptives Sector?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

How Does Regional Performance Compare Across The Contraceptives Industry?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model